2019
DOI: 10.1016/j.ijpharm.2018.11.051
|View full text |Cite
|
Sign up to set email alerts
|

Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 43 publications
0
5
0
Order By: Relevance
“…Therefore, different methods to be applied for the invitro bioavailability testing for samples in the oral cavity. 33 As a result, dissolution was performed in FaSSGF and FaSSIF solutions only.…”
Section: Assaymentioning
confidence: 99%
“…Therefore, different methods to be applied for the invitro bioavailability testing for samples in the oral cavity. 33 As a result, dissolution was performed in FaSSGF and FaSSIF solutions only.…”
Section: Assaymentioning
confidence: 99%
“…Using data from the BT0 sensor, the bitterness threshold of CPM was calculated to be 1.2 mM or 0.47 mg/mL, meaning any concentration above this point is expected to exert a bitterness response by the person tasting it, and therefore requires taste-masking. Since the clinical CPM dose is between 1 mg and 4 mg [57], and the average human secretes 1 mL of saliva per minute [58], this threshold is below the clinical dose and therefore taste-masking of this drug is essential. In the literature the human bitterness threshold of CPM was reported to be 0.506 mg/mL or approximately 1.3 mM [59].…”
Section: Bitterness Thresholdmentioning
confidence: 99%
“…Pharmaceutics 2021, 13, x FOR PEER REVIEW 19 of 23 mg and 4 mg [57], and the average human secretes 1 mL of saliva per minute [58], this threshold is below the clinical dose and therefore taste-masking of this drug is essential.…”
Section: Formulations Taste-assessmentmentioning
confidence: 99%
“…RUP loading was in the range from 0.4 to 0.5 mg-the lowest values were marked for F8, F12, F16 and they did not meet pharmacopoeial requirements (<85%) [25]. Disintegration time tests, conducted under conditions imitating those prevailing in the oral cavity (2-7 mL) are recommended [50][51][52][53], therefore tests in vivo with healthy volunteers, on petri dishes and using a texture analyzer were utilized. Regardless of the method, disintegration time of all ODMT formulations was below 30 s, and most formulations disintegrated even below 15 s. The longest disintegration time was recorded for F13, F14, F15, F16-19-24 s. In all tablets, wetting time below 30 s was noted.…”
Section: Pharmaceutical Evaluation Of Odmtmentioning
confidence: 99%